» Articles » PMID: 30302596

Melanocyte Activation and Skin Barrier Disruption Induced in Melasma Patients After 1064 nm Nd:YAG Laser Treatment

Overview
Journal Lasers Med Sci
Publisher Springer
Date 2018 Oct 11
PMID 30302596
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Melasma is a frequently acquired hyperpigmentary skin disorder, for which several therapies are available. Among them, 1064 nm QS Nd:YAG laser therapy is an effective method, but the recurrence rate of laser treatment is still high. The aim of the present study was to elucidate the mechanism of the high relapse rate of melasma after 1064 nm Nd:YAG laser treatment. Twenty-five female melasma patients were treated with 1064 nm Nd:YAG laser for 10 times. The lesional skin and non-lesional skin were evaluated by means of a reflectance confocal laser scanning microscope before and after laser treatment. Melanin content and transepidermal water loss (TEWL) were measured by an MPA9 skin multifunction tester accordingly. The melanin index value was significantly decreased in the lesional skin after laser treatment, while the non-lesional skin had no difference. The dendritic cells were observed at the level of the dermal-epidermal junction (DEJ) in the lesions of 8 patients before laser treatment, while after laser treatment, the dendritic cells were observed in all 25 subjects. Moreover, there was significant difference between the TEWL value of the lesions before and after laser treatment. Furthermore, the TEWL value was higher in lesions of the 8 subjects which had dendritic cells compared with other 17 subjects which had no dendritic cells, no matter before or after laser treatment. The relapse patients of melasma had higher TEWL value compared with the non-relapse patients. Melanocyte activation and skin barrier disruption may be related to the high relapse rate of melasma after laser treatment.

Citing Articles

Modulation of Melanocyte in Melasma Patients After Picosecond Laser Treatment.

Chen C, Chen C, Tsai F, Chen I, Huang L, Yen Y J Cosmet Dermatol. 2024; 24(1):e16569.

PMID: 39282999 PMC: 11743044. DOI: 10.1111/jocd.16569.


An Update on New and Existing Treatments for the Management of Melasma.

Gan C, Rodrigues M Am J Clin Dermatol. 2024; 25(5):717-733.

PMID: 38896402 PMC: 11358250. DOI: 10.1007/s40257-024-00863-2.


Taxifolin as a Promising Ingredient of Cosmetics for Adult Skin.

Micek I, Nawrot J, Seraszek-Jaros A, Jenerowicz D, Schroeder G, Spizewski T Antioxidants (Basel). 2021; 10(10).

PMID: 34679758 PMC: 8533573. DOI: 10.3390/antiox10101625.

References
1.
Cho S, Kim J, Kim M . Melasma treatment in Korean women using a 1064-nm Q-switched Nd:YAG laser with low pulse energy. Clin Exp Dermatol. 2009; 34(8):e847-50. DOI: 10.1111/j.1365-2230.2009.03599.x. View

2.
Kang H, Bahadoran P, Suzuki I, Zugaj D, Khemis A, Passeron T . In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution. Exp Dermatol. 2010; 19(8):e228-33. DOI: 10.1111/j.1600-0625.2009.01057.x. View

3.
Mun J, Jeong S, Kim J, Han S, Kim I . A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis. J Electron Microsc (Tokyo). 2010; 60(1):11-8. DOI: 10.1093/jmicro/dfq068. View

4.
Kang H, Suzuki I, Lee D, Ha J, Reiniche P, Aubert J . Transcriptional profiling shows altered expression of wnt pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma. J Invest Dermatol. 2011; 131(8):1692-700. DOI: 10.1038/jid.2011.109. View

5.
Zhou X, Gold M, Lu Z, Li Y . Efficacy and safety of Q-switched 1,064-nm neodymium-doped yttrium aluminum garnet laser treatment of melasma. Dermatol Surg. 2011; 37(7):962-70. DOI: 10.1111/j.1524-4725.2011.02001.x. View